The influence of lipoprotein(a) on aortic valve calcification in patients undergoing transcatheter aortic valve replacement
Lp(a) might not exert a significant effect on calcification levels or all-cause mortality in patients undergoing TAVR. Despite the study's highly selected population, these results align with current research, supporting the assumption that the influence of Lp(a) may be confined to the early stages of AS and its progression.
Authors
- Muhammed Gerçek (ORCID: https://orcid.org/0000-0002-1822-936X)
- Kai Friedrichs (ORCID: https://orcid.org/0000-0001-9546-3048)
- Volker Rudolph (ORCID: https://orcid.org/0000-0001-5385-6839)
- Felix Rudolph (ORCID: https://orcid.org/0000-0003-4948-6438)
- Max J. Miller (ORCID: https://orcid.org/0000-0002-1335-9499)
- Sabine Bleiziffer (ORCID: https://orcid.org/0000-0001-9669-7372)
- Johannes Kirchner (ORCID: https://orcid.org/0009-0004-8357-1323)
- Johanna Bormann
- Tanja K. Rudolph (ORCID: https://orcid.org/0000-0001-8839-7476)
- Sara Waezsada
Institutions
- Heart and Diabetes Center North Rhine-Westphalia (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1007/s00392-024-02587-z
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.80